ACADEMIC QUALIFICATIONS

• Postdoc. Jawaharlal Nehru Centre for Advanced Scientific Research – JNCASR (DST, Govt. of
• Bacterial endotoxin mediated sepsis/inflammation and Computational Biology @ Indian Institute of Technology (IIT), Govt. of India.
• Ph.D. Molecular Medicine and Drug Discovery, VIT Vellore, India.
• M.Tech. Biotechnology, Bharath University, India (2nd PG degree).
• M.Sc. Microbiology, Manonmaniam Sundaranar University, India
• B.Sc. Zoology, Manonmaniam Sundaranar University, India.

PUBLICATIONS - JOURNAL and CONFERENCE AND GENEBANK (NCBI)

• Journal Publications: International: 80+; National: 20+
• Citations: 2600+; h-index: 24
• Conference Publications: 94 (International: 64; National: 30); Participated: 100+
• GeneBank (NCBI) Submissions: 9

AWARDS AND HONORS

• NCIFCB-2018 Young Scientist Award-by Sri Venkateshwara University, Tirupati, India. Mar-2018.
• ABAP-2017 Young Scientist Award-by ABAP (Association of Biotechnology and Pharmacy) and University of Hyderabad, India. Dec- 2017.
• SBMLS-2016 Young Scientist Award-by AIIMS New Delhi & SBMLS (Society of Biomedical Laboratory Scientists, India) Dec-2016
• Editorial Member: Advanced Chemicobiology Research (ACBR) from March-2020

PUBLICATIONS

• Shanmugha Samy, Milind Shrinivas D, and Manikandan A*. Novel Pyrazole-biphenyl-carboxamides for SARS-CoV2 entry-level restriction and microbial infections, J Heterocyclic Chem 2024; DOI:10.1002/jhet.4780 (Wiley, IF: 2.4) (ISSN: 0968-0896).
• Deena GRM, Manikandan A*, Subha C, Abishek S, Tejaswini P, Jeevitha S, Palaniraja S. EGFR kinase inhibiting amino-enones for breast cancer; CADD approach, Curr. Comput. Aided Drug Des. 2023, DOI: 10.2174/0115734099266822231219073332 (IF: 1.639) (Bentham, ISSN: 1875-6697).
• Jeevitha S, Manikandan A*, Pavan P, and Rubalakshmi G. Anticandidal effect of novel imidazole derivatives over aspartic proteases inhibition, Chem. Biodivers., 2024, e202301276, 1-5. DOI: 10.1002/cbdv.202301276 (Wiley: IF: 2.9, ISSN:1612-1880).
• Manikandan A*, Jeevitha S, Laharika V, Peptidomimetics for CVD screened via TRADD-TRAF2 complex interface assessments, In Silico Pharmacol., 2023, 11(1):28, DOI: 10.1007/s40203-023-00166-0 (Springer; IF: 2.724; e-ISSN: 2193-9616)
• . Pavan Kumar P, Manikandan A, Akbar P, Ravinder D, Deepthi P, Smita C.P. Entrectinib a plausible inhibitor for Osteopontin (SPP1) in Cervical Cancer - Integrated Bioinformatic Approach. Appl Biochem Biotechnol (2023). https://doi.org/10.1007/s12010-023-04541-7 (Springer; IF: 2.724; ISSN:1470-8744)
• Vemula Vani, Amarnath SM, Sanjay P, Suman B M, Mamatha S E, Swathi A, Priyanka Seal, Manikandan A,* Fragment-based design and MD simulations of Human Papilloma Virus-16 E6 protein inhibitors. J. Biomol. Struct. Dyn. 2024, 42:1, 288-297, DOI: 10.1080/07391102.2023.2203775 (IF: 5.235) (Tail & Fran, ISSN: 1538-0254).
• Vemula Vani, Snehalatha V, Rachel Nishitha, Hima S, Arpitha B H, Manikandan A,* In silico analysis of natural inhibitors against HPV E6 protein. Curr Comput Aided Drug Des. 2024;20(3):303-311. DOI: 10.2174/1573409919666230310144550 (IF: 1.639) (Bentham, ISSN: 1875-6697).
• Ajitha G, Manikandan A, Pavan Kumar JGS, Harishkumar M, Rama Jayaraj, K M Gothandam. Apoptosis-inducing metabolite from marine mangrove actinobacteria VITGAP173. Anticancer Agents Med Chem. 2022; 22:1-7. DOI: 10.2174/1871520622666220523155905. (IF: 2.527) (Bentham, ISSN: 1871-5206).
• Deena Gladies RM, Manikandan A*, Palaniraja S, Sivakumar A, Subha C. Antimicrobial effects of vanillin-based pyridyl-benzylidene-5-fluoroindolins. J Heterocyclic Chem 2021; 58: 1515– 1524, DOI: 10.1002/jhet.4277 (Wiley, IF: 2.4) (ISSN: 0968-0896)
• Manikandan A, Sajjan R, Mirza S Baig. Structure-based design of novel peptidomimetics targeting the SARS-CoV-2 spike protein. Cel. Mol. Bioeng. 2021, 14, 177–185. DOI: 10.1007/s12195-020-00658-5 (Springer, IF: 3.337) (E-ISSN: 1865-5033).
• Uzma Saqib, Masood A. Khan, Manikandan A, Suraj P. Parihar, Mirza S. Baig. Natural compounds as Antiatherogenic agents. Cellular and Molecular Biology, 2021, 67 (1), 177-188, (IF: 1.77) (ISSN: 0145-5680) Doi: http://dx.doi.org/10.14715/cmb/2021.67.1.27.
• Sajjan R, Manikandan A, Mirza S Baig. Dual Targeting of 3CLpro and PLpro of SARS-CoV-2: A Novel Structure-Based Design Approach to treat COVID-19. Current Research in Structural Biology, 2021, 3, 9-18. (Elsevier, IF: 0.56) https://doi.org/10.1016/j.crstbi.2020.12.001. (ISSN: 2665-928X).
• Deena Priscilla H, Jasmine R, Rajesh Kumar M, Annapoorani S, and Manikandan A*. Exploration of anti-breast cancer effects of Terminalia chebula extract on DMBA induced mammary carcinoma in Sprague Dawley rats. Future Journal of Pharmaceutical Sciences, 2020, 6, 108. DOI: https://doi.org/10.1186/s43094-020-00124-z (Springer Nature, IF: 2.6) (ISSN: 2314-7245).
• Baig MS, Manikandan A, Rajpoot S, Saqib U. Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells. Drugs R D, 2020, 20, 161–169. doi: https://doi.org/10.1007/s40268-020-00312-5. (Springer, IF: 3.203) (ISSN: 1179-6901)
• Sherlin RA, Nargis BT, Karthikeyan M, John MJ, Manikandan A*. TRAF2 and NCK-Interacting Kinase Inhibitors for Colorectal Cancer: In Vitro and Theoretical Validations. ACS Comb. Sci. 2020, 22 (11), 608–616. doi: https://pubs.acs.org/doi/10.1021/acscombsci.0c00027 (ACS, IF: 3.381) (ISSN: 2156-8944)
• Manikandan A, Sivakumar A, Poonam SN, and Napoleon AA. Anticancer effects of novel tetrahydro-dimethyl-xanthene-diones. Anticancer Agents Med Chem. 2020; 20(7):909-916 (Bentham) doi: 10.2174/1871520620666200318094138. (IF: 2.527) (ISSN: 1871-5206)
• M. Rajesh Kumar, V. Violet Dhayabaran, N. Sudhapriya, A. Manikandan*, D.A. Gideon, S. Annapoorani. p-TSA. H2O mediated one-pot, multi-component synthesis of isatin derived imidazole as dual-purpose drugs against inflammation and cancer, Bioorganic Chemistry 2020, 102, 104046. doi: https://doi.org/10.1016/j.bioorg.2020.104046. (IF: 5.307) (ISSN: 0045-2068)
• Manikandan A, Vanshika S, Manisha Shah, Sivakumar A, Mohandoss S, Napoleon AA. Pro- and anti-inflammatory cytokine expression levels in macrophages; an approach to develop indazolpyridin-methanones as novel inflammation medication. Antiinflamm. Antiallergy Agents Med. Chem. 2020;19(4):425-435. Doi:10.2174/1871523019666191226104724 (Bentham IF: 0.676).
• Arif M, Hayser B, S. Alyar, Manikandan A, Synthesis, DFT calculations, biological investigation, molecular docking studies of β-lactam derivatives, Journal of Molecular Structure 2020, 1208, 127891, doi:10.1016/j.molstruc.2020.127891. (Elsevier, IF: 3.841) (ISSN: 0022-2860)
• B. Bindu, S. Vijayalakshmi, A. Manikandan*. Synthesis and discovery of triazolo-pyridazine-6-yl-substituted piperazines as effective anti-diabetic drugs; evaluated over dipeptidyl peptidase-4 inhibition mechanism and insulinotropic activities. Eur. J. Med. Chem. 2020, 187, 111912 (IF: 7.088). doi: https://doi.org/10.1016/j.ejmech.2019.111912. (ISSN: 0223-5234).
• Kadirappa A, Manikandan A*, Pramod Kumar and Napoleon A.A. Improved multi-component, one-pot synthesis of functionalized tetrahydropyrans cardiovascular dysfunction regulators. J Heterocyclic Chem. 2020; 57:1403–1413. DOI: https://doi.org/10.1002/jhet.3876 (IF: 2.4) (ISSN:1943-5193).
• Thanigaivelan A, Manikandan A, Reshika GA, Sathishkumar M, Sathiyanarayanan KI, A sustainable synthesis of green carbon quantum dot (CQD) from Catharanthus roseus (white flowering plant) leaves and investigation of its dual fluorescence responsive behavior in multi-ion detection and biological applications, Sustainable Materials and Technologies 2020, 23, e00138, (IF: 10.681) doi: https://doi.org/10.1016/j.susmat.2019.e00138 (ISSN: 2214-9937).
• Dennis BJ, Manikandan A*, Thangarasu P, Sivakumar K. Synthesis and discovery of pyrazolo- pyridine analogs as inflammation medications through pro- and anti-inflammatory cytokine and COX-2 inhibition assessments. Bioorg. Chem. 2020, 94, 103484 (IF: 5.307) (ISSN: 0045-2068) doi: https://doi.org/10.1016/j.bioorg.2019.103484.
• Ashok SR, Shivananda MK, Shet PM, Sreenivasa S, and Manikandan A*, Synthesis and discovery of N-(1-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)-[1,1'-biphenyl]-2-carboxamide derivatives as antimicrobial agents. J Heterocyclic Chem. 2020; 57:1211–1219. (ISSN:1943-5193) (IF: 2.4) DOI: https://doi.org/10.1002/jhet.3857.
• Dennis BJ, Manikandan A*, Thangarasu P, and Sivakumar K. Synthesis and biological activities of nitro-hydroxy-phenylquinolines; validation of antibiotics effect over DNA gyrase inhibition and anti-microbial activity. J Heterocyclic Chem. 2020; 57:1143–1153, (IF: 2.4). (ISSN:1943-5193) DOI: https://doi.org/10.1002/jhet.3851.
• B. Bindu, S. Vijayalakshmi, A. Manikandan*. Discovery, synthesis and molecular substantiation of N-(benzo[d]thiazol-2-yl)-2-hydroxyquinoline-4-carboxamides as anticancer agents. Bioorg. Chem., 2019, 91, 103171. DOI: https://doi.org/10.1016/j.bioorg.2019.103171. (IF: 5.307) (ISSN: 0045-2068)
• Arif M, Neslihan D, Ahmet D, Ahmet C, Manikandan A, Sivakumar A. Discovery of Novel Sulfonamide?Based 5?Arylidenerhodanines as Effective Carbonic Anhydrase (II) Inhibitors: Microwave?Assisted and Ultrasound?Assisted One?Pot Four?Component Synthesis, Molecular Docking, and Anti?CA II Screening Studies. J. Heterocyclic Chem., 2019, 56 (9), 2460– 2468. https://doi.org/10.1002/jhet.3635 (IF: 2.4) (ISSN:1943-5193).
• N. Sudhapriya, A. Manikandan*, M.R. Kumar, P.T. Perumal. Cu-mediated synthesis of differentially substituted diazepines as AChE inhibitors; validation through molecular docking and Lipinski’s filter to develop novel anti-neurodegenerative drugs. Bioorg. Med. Chem. Lett, 2019, 29 (11), 1308-1312. DOI: https://doi.org/10.1016/j.bmcl.2019.04.002 (IF: 2.94) (ISSN: 0960-894X)
• S.R. Ashok, M.K. Shivananda, A. Manikandan*, R. Chandrasekaran. Discovery and synthesis of 2-amino-1-methyl-1H-imidazole-4(5H)-ones as GPCR ligands; an approach to develop breast cancer drugs via GPCR associated PAR1 and PI3Kinase inhibition mechanism, Bioorg. Chem., 2019, 86, 641-651. DOI: https://doi.org/10.1016/j.bioorg.2019.02.048 (IF: 5.307) (ISSN: 0045-2068)
• Manikandan A, Divakar D, Poonam SN*. Phospholipid—the dynamic structure between living and non-living world; a much obligatory supramolecule for present and future. AIMS Molecular Science, 2019, 6 (1): 1–19. Doi: https://doi.org/10.3934/molsci.2019.1.1 (ISSN: 2372-0301)
• Thangarasu P, Manikandan A, Thamaraiselvi S*. Discovery, synthesis and molecular corroborations of medicinally important novel pyrazoles; Drug efficacy determinations through in silico, in vitro and cytotoxicity validations, Bioorg. Chem., 2019, 86, 410-419. (IF: 5.307) (ISSN: 0045-2068) DOI: https://doi.org/10.1016/j.bioorg.2019.02.003
• Arif M, Ozlem F, Ahmet D, Neslihan D*, Manikandan A, Sivakumar A, Piperazine-Azole- Fluoroquinolone Hybrids: Conventional and Microwave Irradiated Synthesis, Biological Activity Screening and Molecular Docking Studies, Bioorg. Chem., 2019, 85, 308-318. DOI: https://doi.org/10.1016/j.bioorg.2019.01.009 (IF:5.307) (ISSN: 0045-2068)
• Palaniraja S, Chandrasekaran R, Selvaraj A, Sivakumar A, Manikandan A*, Pharmacological explorations of eco-friendly amide substituted (Z)-β-enaminones as anti-breast cancer drugs. Arch Pharm (Weinheim) 2019; 352(1): e1800244. DOI: https://doi.org/10.1002/ardp.201800244 (IF: 4.613) (ISSN:1521-4184)
• Manikandan A, Vivek PM, Monic A, Mohammed HA, Sathiyanarayanan KI, Sivakumar A*, Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking. Mol. Inf. 2018, 37 (12), 1800048. Doi: https://doi.org/10.1002/minf.201800048 (IF: 4.050) (ISSN:1868-1751)
• P. Thangarasu, S. Thamaraiselvi, A. Manikandan*, Unveiling novel 2-cyclopropyl-3-ethynyl-4- (4-fluorophenyl) quinolines as GPCR ligands via PI3-kinase/PAR-1 antagonism and platelet aggregation valuations; Development of a new class of anticancer drugs with thrombolytic effects, Bioorg. Chem., 2018, 81, 468-480. DOI: https://doi.org/10.1016/j.bioorg.2018.09.011 (IF: 5.307) (ISSN: 0045-2068)
• Thangarasu P, Manikandan A*, Thamaraiselvi S. Drug efficacy of novel 3-O-methoxy-4-halo di-substituted 5,7-dimethoxy chromans; evaluated via of DNA gyrase inhibition, bacterial cell wall lesion, and antibacterial prospective. Bioorg. Med. Chem. 2018, 26 (12), 3438–3452. DOI: https://doi.org/10.1016/j.bmc.2018.05.016 (IF: 3.641) (ISSN: 0968-0896)
• Arif M, Neslihan D*, Ahmet D, Nesrin C, Faik AA, Manikandan A, Sivakumar A. Synthesis, Biological Activity and Structure-Activity Relationship studies of Novel Conazole Analogues via Conventional, Microwave, and Ultrasound Mediated Techniques, Bioorg. Chem., 2018, 81, 55-70. DOI: https://doi.org/10.1016/j.bioorg.2018.07.036 (IF: 5.307) (ISSN: 0045-2068)
• M. Rajesh Kumar, A. Manikandan, A. Sivakumar, V. Violet Dhayabaran*, An eco-friendly catalytic system for multi-component, one-pot synthesis of novel spiro-chromeno indoline-triones and their anti-prostate cancer potentials evaluated via alkaline phosphatase inhibition mechanism, Bioorg. Chem., 2018, 81, 44-54. DOI: https://doi.org/10.1016/j.bioorg.2018.07.037 (IF: 5.307) (ISSN: 0045-2068)
• Rajesh R, Manikandan A, Nagaraju N*. Synthesis and drug efficacy validations of racemic substituted benzimidazoles as antiulcer/anti-gastric secretion agents. Future Med Chem. 2018; 10(15):1805-1820. DOI: https://doi.org/10.4155/fmc-2017-0214 (IF: 4.767) (ISSN (P): 1756-8919, ISSN (O): 1756-8927)
• M. Rajesh Kumar, Manikandan A, Violet DV*. Synthesis and Molecular Drug Efficacy of Indoline-based Dihydroxy-thiocarbamides: Inflammation Regulatory Property Unveiled over COX-2 Inhibition, Molecular Docking, and Cytotoxicity Prospects. J. Heterocyclic Chem., 2018, 55 (7), 1658-1668. DOI: https://doi.org/10.1002/jhet.3201 (IF: 2.4) (ISSN:1943-5193).
• Kadirappa A, Manikandan A, Sailaja M, AA Napoleon*. Synthesis of substituted quinolinylethers based inhibitors of PI3Kinase as potential anticancer agents. J. Heterocyclic Chem., 2018, 55 (7), 1669-1677. DOI: https://doi.org/10.1002/jhet.3202 (IF: 2.4) (ISSN:1943-5193).
• Chelli SM, Manikandan A, Sridhar P, Sivakumar A, Siva Kumar B, Sabbasani RR*. Drug repurposing of novel quinoline acetohydrazide derivatives as potent COX-2 inhibitors and anti- cancer agents. J. Mol. Struct 2018, 1154, 437-444. Doi: https://doi.org/10.1016/j.molstruc.2017.10.075 (IF: 3.841) (ISSN: 0022-2860)
• Rajesh KM, Manikandan A, Violet DV. N-substituted Hydroxynaphthalene imino-oxindole derivatives as a new class of pi3-kinase inhibitor and breast cancer drug: Molecular validation and SAR studies. Chem Biol Drug Des. 2018; 91 (1), 277–284. DOI: https://doi.org/10.1111/cbdd.13079 (IF: 2.873) (ISSN:1747-0285)
• Manikandan A, Pearl M, Sathiskumar M, Muñoz GC, Sivakumar A*. Therapeutic investigations of novel Indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential. Eur. J. Med. Chem. 2017, 141, 417-426. DOI: https://doi.org/10.1016/j.ejmech.2017.09.076 (Elsevier, IF: 7.088). (ISSN: 0223-5234)
• Manikandan A, Ravichandran S, Sathiyanarayanan K.I, Sivakumar A*. Efficacy and rationale of 2-(4-phenylquinolin-2-yl) phenols as COX-2 inhibitors; an approach to emergent small molecules as the anti-inflammatory and analgesic therapeutics. Inflammopharmacology, 2017, 25 (6), 621-631 Doi: https://doi.org/10.1007/s10787-017-0342-3 (Springer, IF: 5.093) (ISSN: 1568-5608)
• Manikandan A and Sivakumar A*. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents, Bioorg. Med. Chem., 2017; 25(4):1448-1455, DOI: https://doi.org/10.1016/j.bmc.2017.01.007 (Elsevier, IF: 3.641) (ISSN: 0968-0896)
• Manikandan A and Sivakumar A. Molecular explorations of substituted 2-(4-phenylquinolin-2-yl) phenols as phosphoinositide 3-kinase inhibitors and anticancer agents. Cancer Chemother Pharmacol 2017, 79 (2): 389-397. DOI: https://doi.org/10.1007/s00280-016-3227-z (Springer, IF: 3.333). (ISSN: 0344-5704 (P), 1432-0843 (O))
• Rajesh R, Manikandan A, Sivakumar A, Ramasubbu C, Nagaraju N*. Substituted methoxybenzyl-sulfonyl-1H-benzo[d]imidazoles evaluated as effective H+/K+-ATPase inhibitors and anti-ulcer therapeutics. Eur. J. Med. Chem. 2017, 139, 454-460, (IF: 7.088) (ISSN: 0223-5234) DOI: https://doi.org/10.1016/j.ejmech.2017.08.001
• Vivek P.M, Manikandan A, and Sathiyanarayanan K.I*. Iodine catalyzed the three-component synthesis of 1-((2-hydroxy naphthalene-1-yl) (phenyl)(methyl) pyrrolidine-2-one derivatives: rationale as potent PI3K inhibitors and anticancer agents. Bioorg. Med. Chem. Lett. 2017, 27 (11), 2510–2514. DOI: https://doi.org/10.1016/j.bmcl.2017.03.093 (IF: 2.94) (ISSN: 0960-894X)
• P. Sridhar, Manikandan A, B. Ram, Sivakumar A, and S.R. Reddy*. Drugs Against Neurodegenerative Diseases: Design and Synthesis of 6-Amino-substituted Imidazo [1,2-b] pyridazines as Acetylcholinesterase Inhibitors. ChemistrySelect. 2017, 2 (2), 842-847. (IF: 2.307) Doi: https://doi.org/10.1002/slct.201601353 (ISSN:2365-6549)
• Manikandan A, S Ravichandran*, Kumaravel K, Sivakumar A, Rethna P. Molecular docking and in vitro evaluations of Hippocampus trimaculatus (seahorse) extracts as anti-inflammatory compounds. International Journal of Bioinformatics Research and Applications, 2016, 12 (4), 355-371. (Scopus IF: 0.41) (ISSN‎: ‎1744-5485) DOI: https://dx.doi.org/10.1504/IJBRA.2016.080722
• P. Sridhar, Manikandan A, Sivakumar A, and S.R. Reddy*. Synthesis of quinoline acetohydrazide-hydrazone derivatives evaluated as DNA gyrase inhibitors and potential antimicrobial agents. RSC Advances, 2016, 6 (69), 64460 – 64468. Doi: https://dx.doi.org/10.1039/c6ra09891f (RSC Journal, IF: 4.036) (ISSN: 2046-2069)
• Manikandan A and Sivakumar A*. Analgesic, anti-inflammatory and antipyretic evaluations of new Isoquinoline derivatives, Int J Pharm Pharm Sci, 2016, 8(4), 339-343. (Scopus) (ISSN: 0975-1491
• Manikandan A, K.I. Sathiyanarayanan and Sivakumar A*. Molecular docking, design, synthesis, in vitro antioxidant and anti-inflammatory evaluations of new isoquinoline derivatives, Int J Pharm Pharm Sci., 2015, 7 (12) 200-208. (Scopus indexed) (ISSN 0975 - 1491)
• Manikandan A, Sivakumar A. N-substituted (E)-4-arylidene isoquinoline-1,3-dione derivatives as potent anticancer agents, Der Pharma Chemica., 2015, 7 (12), 210-218. (Scopus) (ISSN: 0975-413x)
• Manikandan A, Shipra S, Sri NN, Sivakumar A. Antioxidant and antibacterial studies on essential oils used as alternatives to chemical preservatives, J. Nat. Prod. Plant Resour. 2015, 5 (6):9-14. (Scopus) (ISSN: 2231-3184)
• Manikandan et al. (2023) Bacillus licheniformis strain MANI_2023 16S ribosomal RNA gene, partia - Nucleotide - NCBI (nih.gov) https://www.ncbi.nlm.nih.gov/nuccore/OQ891379
• Manikandan et al. (2018) Escherichia coli strain SAMA_EC 16S ribosomal RNA gene, partial sequence, GenBank: MH588300.1. Link: https://www.ncbi.nlm.nih.gov/nuccore/MH588300
• Manikandan et al. (2018) Bacillus cereus strain SAMA_BC 16S ribosomal RNA gene, partial sequence, GenBank: MH588298.1. Link: https://www.ncbi.nlm.nih.gov/nuccore/MH588298
• Manikandan et al. (2018) Metakosakonia massiliensis strain SAMA_EM 16S ribosomal RNA gene, partial sequence, GenBank: MH588297.1. Link: https://www.ncbi.nlm.nih.gov/nuccore/MH588297
• Manikandan et al. (2018) Staphylococcus haemolyticus strain SAMA_SH 16S ribosomal RNA gene, partial sequence, GenBank: MH588295.1. Link: https://www.ncbi.nlm.nih.gov/nuccore/MH588295
• Manikandan et al. (2018) Klebsiella quasipneumoniae strain SAMA_KQ 16S ribosomal RNA gene, partial sequence, GenBank: MH588274.1. Link: https://www.ncbi.nlm.nih.gov/nuccore/MH588274
• Manikandan et al. (2018) Acinetobacter baumannii strain SAMA1 16S ribosomal RNA gene, partial sequence, GenBank: MH588266.1. Link: https://www.ncbi.nlm.nih.gov/nuccore/MH588266

ABROAD VISITS AND HONORS

• Presented a research work on “Antimicrobial drug discovery” at ELRIG Conference (GSK, Stevenage) during 21-22nd November 2023, GSK, Stevenage, UK.
• Presented a research paper on “Trifluorobenzyl imidazolidine-based DNA gyrase inhibitors for microbial infections” at 2nd Drug Discovery Conference, Riga, Latvia, Europe during, September 22–24, 2022.
• Presented a research paper on “Microbial Secondary Metabolites for Medicinal Applications” during 12-14th of June-2022 at Konventum, Højstrupgård, Helsingør, Denmark, Europe.
• Delivered an invited talk on “(E)-Benzylidene-Indazolpyridin Methanones as Effective Inflammation and Breast Cancer drugs” at 2nd ICSTR Malaysia – International Conference, 28-29 June 2019, Kuala Lumpur, Malaysia. MATTER: International Journal of Science and Technology, p10-11, ISSN 2454-5880.

CONTACT

• Email:manikandan_microbiology@msrcasc.edi.in
  Department of Microbiology
  M.S Ramaiah College of Arts, Science and Commerce
  Bangalore - 560054, India
• Office: 080-23608597